{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:06:59Z","timestamp":1791860819270,"version":"4.3.4"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.psyneuen.2014.03.019","type":"journal-article","created":{"date-parts":[[2014,4,6]],"date-time":"2014-04-06T17:30:31Z","timestamp":1396805431000},"page":"77-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":343,"special_numbering":"C","title":["The plasma levels of various cytokines are increased during ongoing depression and are reduced to normal levels after recovery"],"prefix":"10.1016","volume":"45","author":[{"given":"Johan","family":"Dahl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Ormstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Christian D.","family":"Aass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrik Fredrik","family":"Malt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lil Tr\u00e4skman","family":"Bendz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leiv","family":"Sandvik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Brundin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole A.","family":"Andreassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psyneuen.2014.03.019_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2008.01.004","article-title":"Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: comorbidity between depression and neurodegenerative disorders","volume":"85","author":"Anisman","year":"2008","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.psyneuen.2014.03.019_bib0010","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3389\/fncel.2013.00068","article-title":"Interplay between pro-inflammatory cytokines and growth factors in depressive illnesses","volume":"7","author":"Audet","year":"2013","journal-title":"Front Cell Neurosci."},{"key":"10.1016\/j.psyneuen.2014.03.019_bib0015","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1182\/blood.V87.2.674.bloodjournal872674","article-title":"Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency\u2014possible immunologic and clinical consequences","volume":"87","author":"Aukrust","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.psyneuen.2014.03.019_bib0020","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000097202","article-title":"Passage of cytokines across the blood-brain barrier","volume":"2","author":"Banks","year":"1995","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.psyneuen.2014.03.019_bib0025","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/hup.717","article-title":"IL-6 levels decrease with SSRI treatment in patients with major depression","volume":"20","author":"Basterzi","year":"2005","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.psyneuen.2014.03.019_bib0030","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jad.2008.07.008","article-title":"CSF and plasma cytokines at delivery and postpartum mood disturbances","volume":"115","author":"Boufidou","year":"2009","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psyneuen.2014.03.019_bib0035","first-page":"34","article-title":"Immune aspects in elderly depression: peripheral blood mononuclear cell responses to mitogen stimulation and cytokine plasma concentrations","volume":"9","author":"Brambilla","year":"1997","journal-title":"Aging (Milano)"},{"key":"10.1016\/j.psyneuen.2014.03.019_bib0040","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/1742-2094-9-242","article-title":"Changes in serum and cerebrospinal fluid cytokines in response to non-neurological surgery: an observational study","volume":"9","author":"Bromander","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.psyneuen.2014.03.019_bib0045","series-title":"Goodman and Gilman\u2018s The Pharmacological Basis of Therapeutics","author":"Brunton","year":"2013"},{"key":"10.1016\/j.psyneuen.2014.03.019_bib0050","first-page":"695","article-title":"Pro- versus anti-inflammatory cytokines: myth or reality","volume":"47","author":"Cavaillon","year":"2001","journal-title":"Cell. Mol. Biol. (Noisy -le-grand)"},{"key":"10.1016\/j.psyneuen.2014.03.019_bib0055","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S1566-0702(00)00220-4","article-title":"Neural and humoral pathways of communication from the immune system to the brain: parallel or convergent?","volume":"85","author":"Dantzer","year":"2000","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.psyneuen.2014.03.019_bib0060","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bbi.2006.09.006","article-title":"Twenty years of research on cytokine-induced sickness behavior","volume":"21","author":"Dantzer","year":"2007","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.psyneuen.2014.03.019_bib0065","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jpsychires.2009.05.010","article-title":"Low serum IL-10 concentrations and loss of regulatory association between IL-6 and IL-10 in adults with major depression","volume":"43","author":"Dhabhar","year":"2009","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psyneuen.2014.03.019_bib0070","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2014.03.019_bib0075","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cnr.2006.04.002","article-title":"Effects of cytokines and infections on brain neurochemistry","volume":"6","author":"Dunn","year":"2006","journal-title":"Clin. Neurosci. Res."},{"key":"10.1016\/j.psyneuen.2014.03.019_bib0080","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.pnpbp.2007.09.015","article-title":"Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder","volume":"32","author":"Eller","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2014.03.019_bib0085","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/npp.2012.248","article-title":"Connecting inflammation with glutamate agonism in suicidality","volume":"38","author":"Erhardt","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2014.03.019_bib0090","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.7150\/ijbs.4679","article-title":"Interleukin-6, a major cytokine in the central nervous system","volume":"8","author":"Erta","year":"2012","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.psyneuen.2014.03.019_bib0095","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1017\/S0033291708003723","article-title":"Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study","volume":"39","author":"Gimeno","year":"2009","journal-title":"Psychol. Med."},{"key":"10.1016\/j.psyneuen.2014.03.019_bib0100","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1038\/npp.2011.132","article-title":"The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis","volume":"36","author":"Hannestad","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2014.03.019_bib0105","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.euroneuro.2008.08.001","article-title":"Variations in circulating cytokine levels during 52 week course of treatment with SSRI for major depressive disorder","volume":"18","author":"Hernandez","year":"2008","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psyneuen.2014.03.019_bib0110","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.biopsych.2006.03.075","article-title":"Successful antidepressant therapy restores the disturbed interplay between TNF-alpha system and HPA axis","volume":"60","author":"Himmerich","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2014.03.019_bib0115","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.jpsychires.2010.03.005","article-title":"Regulatory T cells increased while IL-1beta decreased during antidepressant therapy","volume":"44","author":"Himmerich","year":"2010","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psyneuen.2014.03.019_bib0120","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","article-title":"Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis","volume":"71","author":"Howren","year":"2009","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.psyneuen.2014.03.019_bib0125","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1440-1819.2007.01686.x","article-title":"T-helper 1\/T-helper 2 cytokine imbalance and clinical phenotypes of acute-phase major depression","volume":"61","author":"Huang","year":"2007","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.psyneuen.2014.03.019_bib0130","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.pnpbp.2007.03.004","article-title":"Cytokine imbalance in the pathophysiology of major depressive disorder","volume":"31","author":"Kim","year":"2007","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2014.03.019_bib0135","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neulet.2010.08.054","article-title":"Serum anti-inflammatory markers in general population subjects with elevated depressive symptoms","volume":"484","author":"Lehto","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.psyneuen.2014.03.019_bib0140","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.neubiorev.2011.12.005","article-title":"Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression","volume":"36","author":"Leonard","year":"2012","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.psyneuen.2014.03.019_bib0145","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.neubiorev.2013.02.004","article-title":"Depression after myocardial infarction: TNF-alpha-induced alterations of the blood-brain barrier and its putative therapeutic implications","volume":"37","author":"Liu","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"139","key":"10.1016\/j.psyneuen.2014.03.019_bib0150","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jad.2011.08.003","article-title":"Interleukin (IL)-6, tumour necrosis factor alpha (TNF-alpha) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression","author":"Liu","year":"2012","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.psyneuen.2014.03.019_bib0155","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.nurt.2010.07.002","article-title":"Role of microglia in neurotrauma","volume":"7","author":"Loane","year":"2010","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.psyneuen.2014.03.019_bib0160","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0278-5846(93)90045-T","article-title":"Significantly increased expression of T-cell activation markers (interleukin-2 and HLA-DR) in depression: further evidence for an inflammatory process during that illness","volume":"17","author":"Maes","year":"1993","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2014.03.019_bib0165","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1006\/cyto.1997.0238","article-title":"Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression","volume":"9","author":"Maes","year":"1997","journal-title":"Cytokine"},{"key":"10.1016\/j.psyneuen.2014.03.019_bib0170","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.pnpbp.2010.06.014","article-title":"Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression","volume":"35","author":"Maes","year":"2011","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2014.03.019_bib0175","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1056\/NEJM200103293441303","article-title":"Paroxetine for the prevention of depression induced by high-dose interferon alfa","volume":"344","author":"Musselman","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.psyneuen.2014.03.019_bib0180","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jad.2005.07.008","article-title":"Th1, Th2, and Th3 cytokine alterations in major depression","volume":"88","author":"Myint","year":"2005","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psyneuen.2014.03.019_bib0185","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jad.2006.07.013","article-title":"Kynurenine pathway in major depression: evidence of impaired neuroprotection","volume":"98","author":"Myint","year":"2007","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psyneuen.2014.03.019_bib0190","doi-asserted-by":"crossref","first-page":"29355","DOI":"10.1074\/jbc.R200003200","article-title":"Cytokine and cytokine receptor pleiotropy and redundancy","volume":"277","author":"Ozaki","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.psyneuen.2014.03.019_bib0195","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1192\/bjp.bp.109.076430","article-title":"Association of high-sensitivity C-reactive protein with de novo major depression","volume":"197","author":"Pasco","year":"2010","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2014.03.019_bib0200","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jneuroim.2005.08.014","article-title":"Th2 cytokine response in Major Depressive Disorder patients before treatment","volume":"172","author":"Pavon","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.psyneuen.2014.03.019_bib0205","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4088\/JCP.v66n0106","article-title":"Depression during pegylated interferon-alpha plus ribavirin therapy: prevalence and prediction","volume":"66","author":"Raison","year":"2005","journal-title":"J. Clin. Psychiatry"},{"issue":"15","key":"10.1016\/j.psyneuen.2014.03.019_bib0210","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/mp.2009.116","article-title":"CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression","author":"Raison","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2014.03.019_bib0220","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.euroneuro.2007.06.004","article-title":"A detailed examination of cytokine abnormalities in Major Depressive Disorder","volume":"18","author":"Simon","year":"2008","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psyneuen.2014.03.019_bib0225","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0165-1781(96)02783-7","article-title":"Indicators of immune activation in major depression","volume":"64","author":"Sluzewska","year":"1996","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psyneuen.2014.03.019_bib0230","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/0306-9877(91)90272-Z","article-title":"The macrophage theory of depression","volume":"35","author":"Smith","year":"1991","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.psyneuen.2014.03.019_bib0235","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1055\/s-0029-1202263","article-title":"Imbalance between pro- and anti-inflammatory cytokines, and between Th1 and Th2 cytokines in depressed patients: the effect of electroacupuncture or fluoxetine treatment","volume":"42","author":"Song","year":"2009","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.psyneuen.2014.03.019_bib0240","doi-asserted-by":"crossref","first-page":"76396","DOI":"10.1155\/2007\/76396","article-title":"Pro- and anti-inflammatory cytokine balance in major depression: effect of sertraline therapy","volume":"2007","author":"Sutcigil","year":"2007","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.psyneuen.2014.03.019_bib0245","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.pnpbp.2006.01.029","article-title":"Cytokines and serotonin transporter in patients with major depression","volume":"30","author":"Tsao","year":"2006","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2014.03.019_bib0250","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00213-003-1566-z","article-title":"Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder","volume":"170","author":"Tuglu","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.psyneuen.2014.03.019_bib0255","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1158\/1055-9965.EPI-08-0311","article-title":"Reproducibility and correlations of multiplex cytokine levels in asymptomatic persons","volume":"17","author":"Wong","year":"2008","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.psyneuen.2014.03.019_bib0260","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.4088\/JCP.11m07532","article-title":"Toxoplasma gondii immunoglobulin G antibodies and nonfatal suicidal self-directed violence","volume":"73","author":"Zhang","year":"2012","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psyneuen.2014.03.019_bib0265","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/7854_2012_211","article-title":"Inflammation and depression","volume":"14","author":"Zunszain","year":"2013","journal-title":"Curr. Top. Behav. Neurosci."}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453014001152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453014001152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:44:37Z","timestamp":1759682677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453014001152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":52,"alternative-id":["S0306453014001152"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2014.03.019","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The plasma levels of various cytokines are increased during ongoing depression and are reduced to normal levels after recovery","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2014.03.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}